It was reported that the procedure was performed to treat a lesion in the right internal carotid artery.An emboshield nav6 embolic protection system (eps) was used along with a 9x30x136 xact stent delivery system (sds) and a 8x40x136 xact sds.All devices were deployed successfully, however it was reported that the filter of the eps moved distally in the vessel, and the filter faced resistance during removal with the anatomy.The vessel had a spasm, which was treated with an unspecified micro-catheter and 10 units of verapamil were administered.A 3x20mm unspecified balloon dilatation catheter was used, and a dissection was noted.The patient developed a cerebrovascular accident, so the patient was transported to another account.The patient was slowly improving, so a second intervention was deemed unnecessary.The patient was diagnosed with hyperperfusion syndrome, and the occlusion was tight.There was a clinically significant delay in the procedure.No additional information was provided.
|
G9: exemption number e2019001-permits numbering sequence to begin with 10000, to avoid duplication of report numbers due to process transition.There may be gaps in numbering for reports submitted during the transition period.The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the case information, a conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined.The delay in procedure and additional hospitalization were related to case circumstances.The reported patient effects of neurological deficit/dysfunction and stroke are listed in the xact instructions for use as known potential patients effect potentially associated with carotid stents and embolic protection systems.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|